Nanobiotix (NBTX) Cash & Equivalents (2019 - 2025)

Historic Cash & Equivalents for Nanobiotix (NBTX) over the last 7 years, with Q2 2025 value amounting to $32.6 million.

  • Nanobiotix's Cash & Equivalents fell 5976.28% to $32.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $32.6 million, marking a year-over-year decrease of 5976.28%. This contributed to the annual value of $53.8 million for FY2024, which is 3389.54% down from last year.
  • Latest data reveals that Nanobiotix reported Cash & Equivalents of $32.6 million as of Q2 2025, which was down 5976.28% from $53.1 million recorded in Q4 2024.
  • In the past 5 years, Nanobiotix's Cash & Equivalents ranged from a high of $143.5 million in Q2 2021 and a low of $32.6 million during Q2 2025
  • Its 5-year average for Cash & Equivalents is $71.0 million, with a median of $67.1 million in 2023.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 9182.49% in 2023, then crashed by 5976.28% in 2025.
  • Quarter analysis of 5 years shows Nanobiotix's Cash & Equivalents stood at $143.5 million in 2021, then crashed by 70.57% to $42.2 million in 2022, then surged by 91.82% to $81.0 million in 2023, then plummeted by 34.38% to $53.1 million in 2024, then tumbled by 38.62% to $32.6 million in 2025.
  • Its last three reported values are $32.6 million in Q2 2025, $53.1 million for Q4 2024, and $81.1 million during Q2 2024.